Granowitz Craig B
SEC insider (Form 3/4/5 filer). CIK 0001876655. SVP, Chief Medical Officer at LEXICON PHARMACEUTICALS, INC. (LXRX). 12 reported Form 4/5 transactions since Sep 2024; latest on Feb 28, 2026. Located in THE WOODLANDS, TX.
Companies Granowitz Craig B has filed insider reports for
- LEXICON PHARMACEUTICALS, INC. (LXRX): Officer, SVP, Chief Medical Officer
Granowitz Craig B
CIK: 0001876655
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXICON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect35.8K shares- - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Tax PaymentDirect109.1K shares at avg. $1.47$160K - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect74.2K shares- - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect202.3K shares- - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
346.6K shares- - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
519.9K shares- - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect74.2K shares- - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect27.9K shares- - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect35.8K shares- - Feb 28, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
Tax PaymentDirect65.3K shares at avg. $0.67$44K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 35,790 | - | $0 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Tax Payment | 109,098 | $1.47 | $160,374 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 74,226 | - | $0 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 202,260 | - | $0 | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 346,610 | - | - | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 519,920 | - | - | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 74,227 | - | - | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 27,917 | - | - | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 35,790 | - | - | Direct |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Tax Payment | 65,308 | $0.67 | $43,756 | Direct |
1-10 of 12 transactions